Blog

3 Examples of Multiparticulates Enabling Performance a Matrix Tablet Can’t

By Richard Sidwell, Ph.D., Senior Vice President and Chief Scientific Officer | January 11, 2021

For Modified (Controlled) Release Oral Solid Dosage Forms In modified release oral solid dosage forms, matrix tablets dominate the field….

Topics: Modified Release, Oral Solid Dosage

Pros and Cons of Matrix vs. Multiparticulate Formulations

By Richard Sidwell, Ph.D., Senior Vice President and Chief Scientific Officer | December 11, 2020

Should you design your modified release (controlled release) oral solid dosage form…

Topics: Modified Release, Oral Solid Dosage

6 Considerations for Developing Modified Release Versions of Immediate Release Oral Solid Dosage Forms

By Richard Sidwell, Ph.D., Senior Vice President and Chief Scientific Officer, and Wayne Wiley, RPh, Vice President, Regulatory Affairs and Pharmacovigilance | September 10, 2020

Regulatory and CMC Strategy Key for Extended and Controlled Release Products Developing a modified release (MR) formulation of an existing…

Topics: Modified Release, Oral Solid Dosage, Regulatory

Excipient Selection for Successful Formulation Development of Modified Release Oral Solid Dosage Forms

By Myke Scoggins, Director, Product Development | August 6, 2020

Modified release dosage forms offer numerous benefits, but formulation and manufacturing are notoriously challenging and require highly specialized pharmaceutical development…

Topics: Excipient Selection, Formulation Development, Modified Release

Successful Formulation Development of Modified Release Oral Solid Dosage Forms: Release Profiles, High Drug Loads, and Delivery Systems

By Myke Scoggins, Ph.D., Director, Product Development | June 18, 2020

In pharmaceutical manufacturing, modified release dosage forms offer numerous benefits: Drug release over a defined time period Targeted drug release…

Topics: Formulation Development, Modified Release, Release Profile